Research

Snake venom-based antiplatelet drug could cut bleeding risk

by Amirah Al Idrus

A new snake venom-based antiplatelet drug could avoid excessive bleeding associated with other antiplatelet meds.

h.i.v. infected t cell
Research

Could a five-part vaccine be the key to preventing HIV?

by Arlene Weintraub

Scientists led by Duke University believe they've found a way to improve upon RV144, an early HIV vaccine that was just 31% effective in trials.

Biotech

Merrimack poaches Ariad CMO after shake-ups for both companies

by Ben Adams

Following a major reorganization earlier this year that saw it sell off its marketed med and revert back to being a clinical-stage biotech, Merrimack is making…

lillyhq
Biotech

Lilly pays $55M for rights to KeyBioscience’s diabetes assets

by Nick Paul Taylor

Eli Lilly is paying $55 million upfront for the rights to KeyBioscience’s pipeline of treatments for Type 2 diabetes and other metabolic conditions.

Biotech

Roche ditches work on NewLink’s IDO cancer candidate

by Ben Adams

Roche is axing work on IDO med indoximod and handing back the rights to partner NewLink Genetics.

Actelion
Biotech

Actelion antibiotic fails in one phase 3, succeeds in another

by Nick Paul Taylor

Actelion has posted mixed late-phase data on its antibiotic cadazolid.

Biotech

EuroBiotech: More Articles of Note

by Ben Adams

We look at a selection of biopharma stories from across Europe this week.

Biotech

EuroBiotech Report—Novartis’ CAR-T data; Bioblast seeks help

by Ben Adams

Welcome to the latest edition of our weekly EuroBiotech Report as we look at the biggest EU biotech stories of the week.

MedTech

Medtronic’s long-awaited ‘artificial pancreas’ makes U.S. debut

by Amirah Al Idrus

Medtronic’s hybrid closed-loop system, the world’s first “artificial pancreas,” is hitting the U.S. market.

Biotech

As Novartis preps for first CAR-T FDA AdComm, Juliet data revealed

by Ben Adams

Novartis has revealed the long-awaited interim Juliet data for its CAR-T candidate